ASTOUND Trademark

Trademark Overview

On Wednesday, January 24, 2018, a trademark application was filed for ASTOUND with the United States Patent and Trademark Office. The USPTO has given the ASTOUND trademark a serial number of 87768709. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 10, 2022. This trademark is owned by Astellas Pharma Global Development, Inc.. The ASTOUND trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; scientific study and research in the field of pharmaceuticals for prevention of organ transplant rejection
astound

General Information

Serial Number87768709
Word MarkASTOUND
Filing DateWednesday, January 24, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 9, 2018

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "ASTOUND"with the "A" in a stylized format and ashadow effect of the letters.
Goods and ServicesProviding medical and scientific research information in the fields of pharmaceuticals and clinical trials; scientific study and research in the field of pharmaceuticals for prevention of organ transplant rejection

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 5, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Global Development, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062
Party NameAstellas Pharma Global Development, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062

Trademark Events

Event DateEvent Description
Monday, January 10, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2021EXTENSION 5 GRANTED
Monday, May 24, 2021EXTENSION 5 FILED
Friday, May 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 24, 2021TEAS EXTENSION RECEIVED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2020EXTENSION 4 GRANTED
Wednesday, October 28, 2020EXTENSION 4 FILED
Wednesday, October 28, 2020TEAS EXTENSION RECEIVED
Thursday, June 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 2, 2020EXTENSION 3 GRANTED
Tuesday, June 2, 2020EXTENSION 3 FILED
Tuesday, June 2, 2020TEAS EXTENSION RECEIVED
Saturday, October 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 24, 2019EXTENSION 2 GRANTED
Thursday, October 24, 2019EXTENSION 2 FILED
Thursday, October 24, 2019TEAS EXTENSION RECEIVED
Wednesday, March 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 11, 2019EXTENSION 1 GRANTED
Monday, March 11, 2019EXTENSION 1 FILED
Monday, March 11, 2019TEAS EXTENSION RECEIVED
Tuesday, December 4, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 4, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 4, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 23, 2018ASSIGNED TO LIE
Friday, August 3, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 7, 2018NON-FINAL ACTION E-MAILED
Monday, May 7, 2018NON-FINAL ACTION WRITTEN
Saturday, May 5, 2018ASSIGNED TO EXAMINER
Monday, February 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 27, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

astound research pharmaceuticals scientific prevention field transplant rejection study organ clinical